1 Latin American countries have a clinical or subclinical deficiency rate of approximately 40%
North America is anticipated to hold a 43% share of the interstitial cystitis & bladder pain syndrome (IC/BPS) treatment market over the predicted timeframe
Both forms have advantages and potential drawbacks, making it essential to discuss with a healthcare provider before making a decision
The FDA has not evaluated these statements, and nothing on this site is intended to diagnose, treat, cure, or prevent any disease
Some peptides enhance antioxidant enzymes, others safeguard mitochondria, and a few regulate inflammation
The problem is narrower: we still cant answer the basic stuff, what this molecule actually is, whether the body makes it, how its supposed to work, and whether its safe in people